We’re pleased to inform you that Biocytogen will be attending the 16th World Bispecific Summit in Boston MA on September 9th-11th! With the event holding 25+ world-class speakers, Industry-led communities of multi-specific Biopharma and exclusive partnering opportunities. Stop by our booth to meet our team and learn about our achievements and findings in antibody production. We look forward to seeing you there!
What is the 16th World Bispecific Summit?
Partnering with Invenra, the 16th World Bispecific Summit is a premier industry-focused forum, exclusive to bispecific and multispecific drug development. The summit specializes in scientific research across a range of distinctive R&D areas and brings insight and connections through deep discussions about bispecific antibody formats, addressing challenges in stability and production, and exploring novel applications in antibody research. 2025 marks a significant year to revamp strategies across bi- and multi-specific design, immune biology, translational modelling, and clinical differentiation.
Event Overview
Date: September 9th-11th, 2025
Venue: The Royal Sonesta Boston. 40 Edwin H Land Blvd, Cambridge, MA 02142
Event Schedule
For more event information, please refer to Bispecific Full Event Guide .
About BIOCYTOGEN
Biocytogen is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® platforms for fully human monoclonal antibody discovery, and has established a sub-brand, RenBiologics™, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets for worldwide collaboration. Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company's sub-brand, BioMice™, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA(Boston, San Francisco), and Germany (Heidelberg).
We look forward to seeing you in Boston!
